Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ibex (IBEX) EBT (2019 - 2026)

Ibex has reported EBT over the past 7 years, most recently at $15.1 million for Q4 2025.

  • For Q4 2025, EBT rose 29.94% year-over-year to $15.1 million; the TTM value through Dec 2025 reached $53.4 million, up 16.22%, while the annual FY2025 figure was $45.9 million, 12.07% up from the prior year.
  • EBT for Q4 2025 was $15.1 million at Ibex, up from $13.5 million in the prior quarter.
  • Over five years, EBT peaked at $15.1 million in Q4 2025 and troughed at $94000.0 in Q1 2021.
  • A 5-year average of $8.7 million and a median of $9.2 million in 2023 define the central range for EBT.
  • Biggest five-year swings in EBT: plummeted 98.34% in 2021 and later surged 3848.94% in 2022.
  • Year by year, EBT stood at $9.8 million in 2021, then crashed by 59.92% to $3.9 million in 2022, then surged by 86.97% to $7.3 million in 2023, then surged by 58.12% to $11.6 million in 2024, then rose by 29.94% to $15.1 million in 2025.
  • Business Quant data shows EBT for IBEX at $15.1 million in Q4 2025, $13.5 million in Q3 2025, and $11.8 million in Q2 2025.